CHRISTINA MITCHELL: Open Payments
NPI 1346090834 · WELDON SPRING, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,403 in 307 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $2,877 · 2025 $4,403
Food & beverage: $4,392Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $702 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $584 |
| Neurocrine BioSciences, Inc. | 24 | $497 |
| Otsuka America Pharmaceutical, Inc. | 37 | $418 |
| Axsome Therapeutics, Inc. | 27 | $366 |
| Corium, LLC | 29 | $337 |
| Lundbeck LLC | 14 | $241 |
| Vanda Pharmaceuticals Inc. | 18 | $240 |
| Alkermes, Inc. | 21 | $214 |
| Collegium Pharmaceutical, Inc. | 19 | $200 |
Products named: VRAYLAR, REXULTI, CAPLYTA, INGREZZA, Auvelity, Azstarys, FANAPT, ARISTADA.
Industry payments across MO — which companies pay providers there.
